HDAC6 and early-onset autosomal dominant Alzheimer disease: HDAC6 inhibition has been shown to be beneficial for cell protection and survival by enhancing axonal transport of neurotrophic factors during aging and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease (Govindarajan et al.